ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in San Antonio, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Carcinoma
Squamous Cell Carcinoma of Head and Neck
Endometrial Cancer
Non-Small-Cell Lung Carcinoma
Ovarian Cancer

Breast Cancer trials near San Antonio, TX, USA:

Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer (Dauntless-1)

The purpose of this study is to test the safety and tolerability of PMD-026 in patients with metastatic breast cancer. PMD-026 is a ...

Active, not recruiting
Metastatic Breast Cancer
Drug: fulvestrant
Drug: PMD-026

Phase 1, Phase 2

Phoenix Molecular Designs

San Antonio, Texas, United States of America and 4 other locations

Choice (TPC) in advanced metastatic or locally recurrent breast cancer (aMBC) patients with no approved alternative therapies avail...

Enrolling
Breast Cancer
Breast Neoplasm
Drug: Cyclophosphamide
Drug: Interferon infiltration of the inoculation site

Phase 3

BriaCell Therapeutics

San Antonio, Texas, United States and 12 other locations

The goal of this clinical trial is to assess the efficacy of DB-1303/BNT323 compared with investigator's choice chemotherapy in terms of progression-...

Enrolling
Metastatic Breast Cancer
Drug: Paclitaxel
Drug: Nab-paclitaxel

Phase 3

DualityBio

San Antonio, Texas, United States and 44 other locations

participants with metastatic or locally advanced Hormone Receptor (HR) positive and Human Epidermal Growth Factor Receptor (HER)2-negative breast...

Enrolling
Breast Cancer
Locally Advanced Breast Cancer
Drug: Elacestrant Dihydrochloride
Drug: Samuraciclib

Phase 1, Phase 2

Carrick Therapeutics

San Antonio, Texas, United States and 26 other locations

to see if it can be a possible treatment for advanced metastatic breast cancer. This type of cancer would have spread from...

Enrolling
Breast Cancer
Drug: vepdegestrant
Drug: PF-07220060

Phase 1, Phase 2

Pfizer
Pfizer

San Antonio, Texas, United States of America and 10 other locations

Locations recently updated

positive (HR+) and human epidermal growth factor 2 negative (HER2-) breast cancer (BC) and other advanced solid tumors. The main pu...

Enrolling
Hormone-receptor-positive Breast Cancer
Non-small Cell Lung Cancer
Drug: BGB-43395
Drug: Fulvestrant

Phase 1

BeiGene
BeiGene

San Antonio, Texas, United States and 12 other locations

to test the safety of an investigational drug called CFI-402257 alone in advanced solid tumors and in combination with Fulvestrant in advanced breast...

Enrolling
Breast Cancer
Advanced Solid Tumor
Drug: CFI-402257
Drug: Fulvestrant

Phase 1, Phase 2

Treadwell Therapeutics

San Antonio, Texas, United States of America and 3 other locations

doxorubicin (PLD, Doxil) are safe and effective at controlling the cancer in patients with metastatic triple Human Epidermal Growth Factor R ...

Enrolling
Metastatic Breast Cancer
HER2-negative Breast Cancer
Drug: CDX-1140
Drug: PLD Chemotherapy

Phase 1

The University of Texas System (UT)
The University of Texas System (UT)

San Antonio, Texas, United States and 5 other locations

study drug LY3484356 alone or in combination with other anticancer therapies is safe and effective in participants with advanced or metastatic breast...

Active, not recruiting
Endometrial Cancer
Breast Cancer
Drug: Trastuzumab
Drug: Everolimus

Phase 1

Lilly
Lilly

San Antonio, Texas, United States of America and 75 other locations

ovarian function in premenopausal women with HR+, HER2-negative breast cancer and men with HR+ breast cancer. The...

Invitation-only
Breast Cancer
Drug: Exemestane Tablets
Drug: Anastrozole Tablets

Phase 3

Tolmar Pharmaceuticals

New Braunfels, Texas, United States and 11 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems